![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, March 03, 2023 10:53:38 AM
Arman seems ambitious, but also very very naive. obviously he is a bright guy and has a decent general background, but not for CEO at all. he is in wayyyyyyyyyyyyyyyyyyyyyyyyyyyyy over his head imo. heck he only has 8 years TOTAL pharma employment and only 5 of them of any value. and he is essentially running a small biotech??? all on his own??? a biotech that is in an exceedingly difficult position financially and legally??? he has ZERO experience in a lot of the matters he is dealing with. and he is dealing with all of it alone. that is a lot to ask of the guy. i deal with fairly deep depression daily. i could FEEL his struggles in both the october and december calls. i have also been a mid-range professional in over my head before and i can FEEL his struggles and sense his naivete there as well. Arman means well. He is trying very hard to succeed. He has talents that are valuable to any company. If i were important and ran a business, I would want the guy on board. But in his current position, he is in an almost impossible situation.
imo his reprioritization of indications was excellent.
imo the investor presentation was superb. well timed, very well prepared, long overdue.
imo his insider buy was a great strategic move.
imo the rebrand idea is very appropriate and another important strategic move.
imo his somewhat limited plans for moving forward are completely appropriate.
imo he is doing better than i would ever expect in his CEO role, given his lack overall and specific experience.
but, he has made several very questionable statements (this post isn't about that though and i can't say i blame him given the situation he is in and the inevitable stress of it all). i also think he expected the share price to respond better and the financing problem to sort of go away. his inexperience probably played a big part there.
the cytodyn advisory board is also very impressive.
i'll even give Nader some credit. he more or less did everything wrong, but he DID get a load of trials started and a bunch completed. he messed all of them up, but also managed to at least get some positive data signals out there, across many indications. i think he is a lying crook, but also think he absolutely wanted to get the drug approved. unfortunately he didn't understand how the game is played and his overconfidence was debilitating for cytodyn.
the board of directors is absolutely horrendous. couldn't be much worse imo. but this post is not about that so i'll not expound on it.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM